Revenue has scaled aggressively from $3.6M in 2023Q4 to $16.7M in 2026Q1, maintaining net margins above 50% despite inherent sector volatility.
Chicago Atlantic BDC, Inc. (LIEN) annual income statement — 6-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Mar'22 | Mar'21 |
|---|
| Net Interest Income | 51.75M | 48.02M | 19.91M | 11.74M | 0 | 10.07K | 0 |
| NII Growth % | 444.47% | 141.23% | 69.6% | - | -100% | - | - |
| Net Interest Margin % | 0.02% | 14.04% | 6.43% | 13.25% | 0% | 0.01% | 0% |
| Interest Income | 53.95M | 49.27M | 19.91M | 11.74M | 0 | 10.07K | 0 |
| Interest Expense | 2.21M | 1.25M | 0 | 0 | 0 | 0 | 0 |
| Loan Loss Provision | 5.69M | 11.1M | 0 | 0 | 0 | 0 | 0 |
| Non-Interest Income | -1.79M | 5.03M | -1.93M | -1.71M | 4.05M | 0 | 0 |
| Non-Interest Income % | -3.59% | 9.49% | -10.76% | -17% | 100% | 0% | - |
| Total Net Revenue | 49.96M | 53.05M | 17.97M | 10.03M | 4.05M | 10.07K | 0 |
| Revenue Growth % | 58.95% | 195.21% | 79.15% | 147.88% | 40075.37% | - | - |
| Non-Interest Expense | 10.57M | 7.42M | 8.35M | 2.69M | 1.98M | 573.44K | 958.29K |
| Efficiency Ratio | 21.15% | 13.99% | 46.46% | 26.83% | 49.05% | 5692.82% | - |
| Operating Income | 33.71M | 34.53M | 9.62M | 7.34M | 2.06M | -563.37K | -958.29K |
| Operating Margin % | 67.47% | 65.08% | 53.54% | 73.17% | 50.95% | -5592.82% | - |
| Operating Income Growth % | - | 258.83% | 31.1% | 255.97% | 466.02% | 41.21% | - |
| Pretax Income | 31.68M | 33.28M | 9.62M | 7.34M | 1.71M | -563.37K | -958.29K |
| Pretax Margin % | 63.41% | 62.73% | 53.54% | 73.17% | 42.21% | -5592.82% | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | 31.68M | 33.28M | 9.62M | 7.34M | 1.71M | -563.37K | -958.29K |
| Net Margin % | 63.41% | 62.73% | 53.54% | 73.17% | 42.21% | -5592.82% | - |
| Net Income Growth % | 31.95% | 245.85% | 31.1% | 329.72% | 403.2% | 41.21% | - |
| Net Income (Continuing) | 31.68M | 33.28M | 9.62M | 7.34M | 1.71M | -563.37K | -958.29K |
| EPS (Diluted) | 1.39 | 1.46 | 0.93 | 1.18 | 0.31 | -0.64 | -1.09 |
| EPS Growth % | -32.31% | 56.99% | -21.19% | 280.65% | 148.44% | 41.28% | - |
| EPS (Basic) | - | 1.46 | 0.93 | 1.18 | 0.31 | -0.64 | -1.09 |
| Diluted Shares Outstanding | 22.82M | 22.82M | 10.34M | 6.21M | 5.55M | 877.41K | 877.41K |
Quick answers to the most common questions about buying LIEN stock.
For fiscal year 2025, Chicago Atlantic BDC, Inc. (LIEN) reported total revenue of $53.1M.
Chicago Atlantic BDC, Inc. (LIEN) is profitable, generating $33.3M in net income for the fiscal year ending 2025 with a net profit margin of 62.7%.
Chicago Atlantic BDC, Inc. (LIEN) reported an operating income of $34.5M, resulting in an operating profit margin of 65.1%. This margin reflects the operational efficiency of the business before interest and taxes.
Chicago Atlantic BDC, Inc. (LIEN) generated $42.0M in gross profit for the year, representing a gross profit margin of 79.1%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Regulatory dependency on cannabis
Metrics are mathematically derived from official filings.
Rapid Revenue Scaling Through Deployment
As reported in recent financial statements, LIEN has demonstrated significant top-line expansion, with quarterly revenue climbing from $3.6M in 2023Q4 to $16.7M by 2026Q1, reflecting an aggressive deployment of capital into the specialized cannabis credit market that warrants close monitoring for future sustainability.
The sharp revenue trajectory suggests the company has successfully transitioned from its initial capitalization phase to a fully operational lending vehicle. Investors should interpret this growth as a function of portfolio expansion rather than organic yield improvement, as the firm continues to capture high-interest opportunities in a restricted sector.
Structural Margin Resilience Amid Expansion
Based on the provided income statement data, LIEN has maintained robust profitability, with net margins consistently hovering above 50% despite the inherent volatility of the cannabis sector, suggesting that the firm currently possesses significant pricing power within its niche lending environment.
The high gross margin profile indicates that the company is effectively avoiding the interest expense drag common in more leveraged BDCs. However, the recent dip in net margin to 51.1% in 2026Q1 may indicate rising operational costs or a shift in the underlying credit quality of the portfolio.
Operating Efficiency Lacks Scaled Leverage
According to historical income statement figures, LIEN has managed to scale operating income alongside revenue, yet the lack of significant debt-to-equity utilization suggests that the firm has not yet leveraged its balance sheet to amplify returns, leaving potential for future ROE optimization.
The company's ability to generate $9.6M in operating income on $16.7M of revenue in 2026Q1 highlights a lean cost structure. Analysts should monitor whether management intends to introduce leverage to boost earnings, as this would fundamentally alter the risk profile and interest expense burden of the firm.
Earnings Volatility Masks Underlying Performance
As evidenced by the erratic EPS growth, which swung from a 138.9% increase in 2024Q4 to a 50% decline in 2026Q1, the quality of reported net income appears sensitive to non-operating items and potential fluctuations in asset valuations that require deeper scrutiny.
The inconsistency in EPS growth suggests that investors should look past headline figures to understand the underlying cash-generating capacity of the loan portfolio. The absence of stock-based compensation is a positive indicator of shareholder alignment, yet the volatility warrants caution regarding the sustainability of current earnings levels.
Regulatory Arbitrage Risks Future Viability
Based on an analysis of the firm's competitive moat, the current high-yield environment is predicated on federal cannabis restrictions, and any shift in the regulatory landscape could lead to rapid margin compression as traditional, lower-cost capital enters the market to compete with LIEN.
Short-term performance may be masking long-term structural risks associated with the firm's reliance on a restricted credit market. If federal rescheduling occurs, the current yield premiums may evaporate, forcing the company to either accept lower returns or pivot to higher-risk assets to maintain its current profitability.